WINTON MATTHEW (COO) received a stock award from INOZYME PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/2/2025ACC: 0000950170-25-049393
+2.49K
Net shares
Net buyer
$1.9K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2.49K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.49K
Price / share
$0.77
Trade value
$1.92K
% of position
50.8%
3/31/2025
4.90K→7.39K
Total
Net shares
+2.49K
Net value
$1.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2025 | A · Award | +2.49K | $0.77 | $1.92K | 50.8% | 4.90K | 7.39K |
| Total | +2.49K | $1.92K | ||||||
Derivative Transactions0
No derivative transactions reported